city in Montgomery County, Maryland, United States
The Ravens have hosted a slew of players before the NFL draft. A closer look provides some insight.
baltimoresun.com/2024/04/09/ravens-host-players-nfl-draft/
Man sentenced to six years in prison for lying to grand jury investigating death of Maryland football coach Mike Locksley’s son
baltimoresun.com/2024/03/29/meiko-locksley-sentence-maryland-football/
Kayla DiCello takes gold in USA Gymnastics Winter Cup. Olympic champ Sunisa Lee falls on bars, beam
apnews.com/article/usa-gymnastics-olympics-dicello-lee-f34d2d603c2702bc183514f8c2da4c0f
IKEA opening new small-format stores across U.S.: Like other retailers, the furniture brand wants to make it easy for shoppers to buy online and in-person.
axios.com/2024/04/01/ikea-new-small-stores-plan-and-order
Grandpa with ‘beginner’s luck’ wins big lottery prize. Now he wants to help grandkids
sacbee.com/news/nation-world/national/article285063032.html
Former River Hill star Beau Brade among 4 Maryland football players invited to NFL scouting combine
baltimoresun.com/2024/02/13/maryland-football-nfl-scouting-combine/
On This Day, Jan. 4: Nancy Pelosi is 1st woman elected speaker of the House - UPI.com
upi.com/Top_News/2023/01/04/On-This-Day-Pelosi-is-1st-woman-elected-speaker-of-the-House/6371672800417/
AstraZeneca, Sanofi RSV infant shots approved in China: AstraZeneca (AZN.L) said on Tuesday that its respiratory syncytial virus (RSV) immunization for infants ...
reuters.com/business/healthcare-pharmaceuticals/astrazeneca-sanofis-rsv-infant-shots-approved-china-2024-01-02/
Designer reveals she cut her vacation short for 'an emergency order' for two matching Chiefs jackets...
dailymail.co.uk/sport/nfl/article-13016539/Taylor-Swift-allegedly-makes-emergency-order-Chiefs-Ravens-Travis-Kelce-Brittany-Mahomes.html
Quick Glance: Charles Barkley criticizes NFL fans over Taylor Swift and football
- Clear message from Charles Barkley to Taylor Swift’s NFL haters
- Criticism of T-Swift for alleged ruining of football
- Speculation on Swift's potential influence on Super Bowl 2024
- Heavy criticism of Swift since her start at Travis Kelce's games in September 2023
New coronavirus variant JN.1 is spreading fast. Here’s what to know.: The WHO declared JN.1 a “variant of interest” as cases spread globally ...
washingtonpost.com/wellness/2023/12/20/new-covid-variant-jn1-symptoms/
Quick Glance: JN.1 Variant: Latest on Covid Developments
- The JN.1 variant may be more transmissible, but does not cause more severe Covid cases.
- Covid cases are on the rise, driven by the JN.1 variant, according to Dr. Mandy Cohen of the Centers for Disease Control and Prevention.
- JN.1 accounts for about 21% of Covid cases in the US, up from 8% just two weeks ago, according to the CDC.
- The World Health Organization has designated JN.1 as a 'variant of interest', indicating genetic changes that could enhance its spread.
Snake Swallows Shift Knob and Lives to Tell the Tale: A snake in Maryland needed emergency surgery to remove a shift knob it swallowed, which wore a hole through ...
thedrive.com/news/snake-swallows-shift-knob-and-lives-to-tell-the-tale
AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal: AstraZeneca (AZN.L) said on Tuesday it had agreed to buy respiratory syncytial virus ...
reuters.com/business/healthcare-pharmaceuticals/astrazeneca-buy-rsv-vaccine-maker-icosavax-11-bln-2023-12-12/
Quick Glance: AstraZeneca's Acquisition of US Vaccine Company in $1.1 Billion Deal
- AstraZeneca is acquiring a Seattle-based company, Icosavax, working on a potential vaccine for two common respiratory diseases.
- The US company's main vaccine targets respiratory syncytial virus (RSV) and human metapneumovirus (hMPV), causing severe illnesses in adults over 60 and those with chronic conditions.
- In intermediate studies, the vaccine demonstrated strong immune responses against RSV and hMPV one month post-vaccination.
- It is a combination protein VLP vaccine given as a single dose.
Lottery ticket catches rideshare driver’s eye on trip — then win has him in disbelief
miamiherald.com/news/nation-world/national/article283058628.html
Novavax's updated COVID-19 vaccine to help provide wider array of choices : SK bioscience began its domestic supply of Novavax’s updated COVID-19 vaccine ...
koreatimes.co.kr/www/tech/2023/12/779_365687.html
Ravens sign RB Jake Funk, former Maryland and Damascus High standout, to practice squad
baltimoresun.com/2023/12/19/ravens-sign-rb-jake-funk-former-maryland-and-damascus-high-standout-to-practice-squad/
Book recommendations on money, investing, and financial independence : Add these to your 2024 book list if you set some financial goals and need some inspiration ...
businessinsider.com/money-investing-book-recommendations-investors-entrepreneurs-build-wealth-financial-independence-2023-12
Vaccination against corona: Novavax vaccine from 11.12. - Questions & Answers: There are many coronavirus cases and deaths again. The RKI calls for vaccination ...
rp-online.de/leben/gesundheit/impfung-gegen-corona-novavax-impfstoff-ab-1112-fragen-und-antworten_aid-102768239
US urges makers of infant RSV shots to meet winter demand
reuters.com/business/healthcare-pharmaceuticals/us-urges-rsv-vaccine-makers-meet-winter-demand-white-house-says-2023-12-07/
WHO authorizes emergency use of Novavax's updated COVID shot: Novavax's (NVAX.O) updated vaccine has been granted emergency-use authorization by the World Health ...
reuters.com/business/healthcare-pharmaceuticals/who-authorizes-emergency-use-novavaxs-updated-covid-vaccine-2023-11-28/
Quick Glance: WHO Approves Novavax's Updated COVID Vaccine
- The World Health Organization (WHO) has granted emergency use authorization for Novavax's updated vaccine for active immunization against COVID-19, approved for individuals aged 12 and older.
- The updated Novavax vaccine targets a descendant of the XBB lineage of the coronavirus that was globally predominant earlier this year.
- Novavax missed out on the COVID-19 vaccine windfall due to manufacturing issues that delayed its approval, and its original COVID shot was only authorized in the US in July 2022.
Health Canada authorizes Novavax's updated COVID shot for Omicron: Novavax (NVAX.O) said on Tuesday that Health Canada had authorized its updated COVID-19 ...
reuters.com/world/americas/health-canada-authorizes-novavaxs-updated-covid-shot-omicron-2023-12-05/
Data suggests that people report fewer side effects after Novavax's Covid vaccine.
Because of that, some people have held out on their booster until they ... Show more
CDC urges public to get XBB vaccine for fast changing COVID-19 - Focus Taiwan: Taipei, Jan. 5 (CNA) People should get at least one shot of the XBB vaccine due to ...
focustaiwan.tw/society/202401050018
Data suggests that people report fewer side effects after Novavax's Covid vaccine.
Because of that, some people have held out on their booster until they ... Show more
Novavax: Do Not Expect A Turnaround In 2024: Novavax faces major challenges in 2024, including a significant Gavi dispute and going concern issues ...
seekingalpha.com/article/4659859-novavax-do-not-expect-turnaround-2024-rating-downgrade
Paid articlePaid
Today’s top business headlines: AstraZeneca acquisition, Apple Watch import ban, State of Hiring
fastcompany.com/91003199/todays-top-business-headlines-astrazeneca-acquisition-apple-watch-import-ban-state-of-hiring
Understanding JN.1: The Latest Omicron Subvariant Adding to COVID-19 Worries: JN.1, a new subvariant of the Omicron strain, has driven up COVID-19 infections and ...
techtimes.com/articles/299917/20231220/understanding-jn-1-latest-omicron-subvariant-adding-covid-19-worries.htm
US FDA approves AstraZeneca's breast cancer drug combination: The U.S. Food and Drug Administration on Thursday approved AstraZeneca's (AZN ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-astrazenecas-breast-cancer-drug-combination-2023-11-16/
Quick Glance: New FDA Approval for AstraZeneca's Breast Cancer Treatment
- Combination of Truqap and older drug offers new treatment option for most common type of breast cancer.
- Approval for adult patients with HR-positive/HER2-negative breast cancer and patients with altered PIK3CA, AKT1, or PTEN genes.
- Extension of progression-free survival by 7.3 months in study with altered genes.
- Common side effects include diarrhea, decreased hemoglobin, nausea, and fatigue.
Vaccine maker Novavax tops revenue estimates, eyes more cost cuts: COVID-19 vaccine maker Novavax (NVAX.O) on Thursday beat market estimates for quarterly ...
reuters.com/business/healthcare-pharmaceuticals/covid-vaccine-maker-novavax-reports-better-than-expected-revenue-2023-11-09/
CDC expedites release of 77,000 additional doses of Sanofi-AstraZeneca's RSV drug
reuters.com/business/healthcare-pharmaceuticals/cdc-releases-77000-additional-doses-sanofi-astrazenecas-rsv-drug-2023-11-16/
AstraZeneca prioritizes US for RSV drug amid surge in cases: AstraZeneca (AZN.L) on Friday said it was prioritizing the U.S. market for additional doses of its ...
reuters.com/business/healthcare-pharmaceuticals/astrazeneca-prioritizes-us-rsv-drug-amid-surge-cases-2023-11-10/
Over 15 million Americans got updated COVID vaccines so far: Over 15 million people in the United States, around 4.5% of the population, had received the updated ...
reuters.com/world/us/over-15-mln-americans-got-updated-covid-vaccines-so-far-2023-11-01/
Order now possible: Adapted COVID-19 vaccine from Novavax: Berlin - Doctors' practices can now use the US manufacturer's protein-based COVID-19 vaccine adapted ...
aerzteblatt.de/nachrichten/147755/Bestellung-jetzt-moeglich-Angepasster-COVID-19-Impfstoff-von-Novavax
A different kind of COVID vaccine is available. Will it make a difference?: While the rollout of updated COVID-19 vaccines is off to a slow start in Georgia and ...
ajc.com/news/health-news/a-different-kind-of-covid-vaccine-is-available-will-it-make-a-difference/6MSMGFH76JCTVLAF3WZVBEG27M/
Emergent BioSolutions: Meaningful Debt, But Narcan Should Grow: Emergent is facing financial challenges, including negative income, high debt ...
seekingalpha.com/article/4653893-emergent-biosolutions-meaningful-debt-but-narcan-will-grow
Paid articlePaid
FDA reviewing at-home flu vaccines: The Food and Drug Administration (FDA) will review an at-home flu vaccine as uptake for the inoculations remains low this ...
thehill.com/policy/healthcare/4274582-fda-reviewing-at-home-flu-vaccines/
Maryland to be home of Premier Lacrosse League’s Whipsnakes as league moves to new model
baltimoresun.com/sports/bs-sp-premier-lacrosse-league-maryland-whipsnakes-20231114-jw7vpdfl25ajxeznsfous5tcia-story.html
Updated Novavax COVID vaccine to arrive in Taiwan in December: CDC - Focus Taiwan
focustaiwan.tw/society/202311080017
COVID-19: Third adapted vaccine approved.: Brussels - The European Commission has approved another COVID-19 vaccine, Nuvaxovid, developed by Novavax and adapted ...
aerzteblatt.de/nachrichten/147025/COVID-19-Dritter-angepasster-Impfstoff-zugelassen
Quick Glance: COVID-19: New Adapted Vaccine Approved
- The European Commission has approved the Nuvaxovid vaccine developed by Novavax.
- It is the first protein-based adapted vaccine approved for the autumn and winter season.
- Vaccinations continue to be our most effective tool against COVID-19.
- The European Medicines Agency (EMA) thoroughly assessed Nuvaxovid.
Is the Novavax COVID Vaccine Better than mRNA Vaccines? What We Know So Far: Scientific American is the essential guide to the most awe-inspiring advances in ...
scientificamerican.com/article/is-the-novavax-covid-vaccine-better-than-mrna-vaccines-what-we-know-so-far/
Quick Glance: Novavax optimistic about updated COVID vaccine availability in the US
- Novavax is encouraged by the broad availability of its updated COVID-19 vaccine in the US.
- Shares of vaccine maker Novavax and rival Moderna were down 6% to 7% after Pfizer expressed concerns about lower-than-expected sales of its COVID-19 vaccine.
- Novavax continues to work closely with the European Medicines Agency (EMA) as the regulator delays a decision on approval for the company's variant-tailored COVID-19 shot.
Next season, you may be able to take your flu vaccine at home: The US Food and Drug Administration is reviewing an application for the nasal spray flu vaccine ...
cnn.com/2023/10/24/health/next-season-you-may-be-able-to-take-your-flu-vaccine-at-home/
A new RSV shot for infants is in short supply: A new shot for infants against RSV is in short supply, and U.S. health officials are telling doctors they should ...
apnews.com/article/rsv-shot-shortage-infants-dc57b7788813cb3c00b081791b4c8ad3
Quick Glance: RSV Drug Shortage Prompts Doctor Alert
- CDC urges prioritizing new RSV drug for vulnerable infants due to limited supply.
- Experts warn of overwhelming demand for Beyfortus, first FDA-approved RSV drug.
- Sanofi reports unprecedented demand for antibody treatment despite aggressive supply plan.
- CDC advises prioritizing 100 mg doses of Beyfortus for infants under 6 months and those with underlying conditions.
EU delays approval of Novavax's revised COVID vaccine - FT: European Union (EU) regulators have delayed a decision to give approval for Novavax's (NVAX ...
reuters.com/business/healthcare-pharmaceuticals/eu-delays-approval-novavaxs-revised-covid-vaccine-ft-2023-10-15/
Updated Novavax COVID-19 vaccine shipped to distributors, to be available this week
reuters.com/business/healthcare-pharmaceuticals/updated-novavax-covid-19-vaccine-shipped-distributors-be-available-this-week-2023-10-09/
Sanofi seeing 'unprecedented' demand for RSV therapy: (This Oct. 20 story has been corrected to show that the drug was co-developed by Sanofi and AstraZeneca in ...
reuters.com/business/healthcare-pharmaceuticals/sanofi-seeing-unprecedented-demand-rsv-therapy-2023-10-20/
Chiefs' Travis Kelce responds to Jets' Aaron Rodgers' 'Mr. Pfizer' comment: Kansas City Chiefs star Travis Kelce responded Friday to New York Jets quarterback ...
yardbarker.com/nfl/articles/chiefs_travis_kelce_responds_to_jets_aaron_rodgers_mr_pfizer_comment/s1_13132_39355362
Another option for COVID-19 vaccinations approved: U.S. regulators on Tuesday authorized another option for fall COVID-19 vaccination: updated shots made by ...
ajc.com/news/health-news/another-option-for-covid-19-vaccinations-approved/APOH5TTLFRFQDH4XYL6DVDFAO4/
Quick Glance: US FDA approves updated Novavax COVID vaccine
- The updated COVID-19 vaccine from Novavax has been authorized by the US Food and Drug Administration for emergency use in individuals aged 12 years and older.
- The company's shares increased by more than 11%.
- Novavax is relying on the commercial sale of its updated vaccine to ensure its economic survival.
- The CDC's Advisory Committee on Immunization Practices (ACIP) will not schedule another meeting to discuss the Novavax vaccine.
AstraZeneca to pay $425 mln to end US lawsuits over heartburn drugs: Britain's AstraZeneca (AZN.L) said it will pay $425 million to settle lawsuits in the United ...
reuters.com/legal/astrazeneca-pay-425-mln-settle-nexium-prilosec-litigation-us-2023-10-03/
Vaccinating to stem the fall Covid wave.: The online edition of the Austrian daily newspaper Die Presse.
diepresse.com/17742005/impfen-zur-eindaemmung-der-herbst-covid-welle
New corona preparations: vaccinations starting today - with adapted omicron vaccines
spiegel.de/panorama/ab-heute-wird-geimpft-mit-angepassten-omikron-impfstoffen-a-83c3515d-475b-448c-b0a2-5548579c1752
Quick Glance: Start of Corona Vaccination Season with Adapted Omicron Vaccines
- Recommended vaccination for vulnerable groups: Biontech, Moderna, and Novavax as adapted vaccines
- Experts predict strain on healthcare system in the fall
- Distribution of adapted Biontech vaccine begins today
- Newly approved adapted vaccines from Moderna and Novavax
Insurance companies deny COVID booster to thousands of people every day. What to know
sacbee.com/news/coronavirus/article279738374.html
Pfizer forecasts 24% COVID vaccination rate in US this year: Pfizer (PFE.N) expects 24% vaccination rate for COVID-19 shots in the United States this year ...
reuters.com/business/healthcare-pharmaceuticals/pfizer-expects-24-uptake-covid-vaccines-us-cfo-2023-09-18/
Europe to decide on Novavax's COVID vaccine in October: The European Medicines Agency (EMA) expects to decide on the use of Novavax's (NVAX ...
reuters.com/business/healthcare-pharmaceuticals/europe-expects-decide-novavaxs-covid-vaccine-october-2023-09-21/
CDC Endorses New COVID-19 Vaccines, Allowing Shots to Begin This Week: The updated shots from Pfizer and Moderna will be available this week ...
usnews.com/news/health-news/articles/2023-09-12/cdc-vaccine-committee-endorses-new-covid-19-shots
Quick Glance: CDC director emphasizes importance of updated COVID booster shot amid increasing cases
- The CDC recommended updated COVID booster shots for Americans aged 6 months and older due to rising cases and hospitalizations across the country.
- In an interview with ABC News Live on Tuesday night, CDC Director Mandy Cohen stressed the importance of getting the updated shot and addressed safety concerns, stating that the shots have been studied 'more than any vaccine in history.'
- The CDC recommends that everyone should get the updated COVID vaccine, and it will be available in doctor's offices and pharmacies across the country in the coming days.
- The CDC director expressed concern that fewer than half of adults over 65 and only 1 in 5 Americans received the booster shot last fall.
Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting Demand
forbesafrica.com/current-affairs/2023/10/17/vaccine-stocks-including-pfizer-moderna-biontech-and-novavax-slide-amid-plummeting-demand/
Quick Glance: BioNTech stock plummets – uncovering the reasons
- BioNTech stock is currently down almost 10%.
- BioNTech is now examining its business.
- Weak demand for COVID-19 vaccines hampers BioNTech's business.
When can I get the new COVID vaccine? Fresh shots OK'd by FDA to hit pharmacies: There's still some debate within the medical community about whether everyone ...
usatoday.com/story/news/health/2023/09/11/new-covid-booster-shots-approved/70825512007/
AstraZeneca seeks to calm CEO speculation after shares drop: AstraZeneca (AZN.L) appeared to play down speculation about the future of its CEO after its shares ...
reuters.com/business/healthcare-pharmaceuticals/astrazeneca-shares-fall-36-7-12-week-low-2023-09-11/
Quick Glance: AstraZeneca Calms CEO Speculation Following Share Drop
- AstraZeneca downplays speculation about CEO's future
- Shares drop over 4% after report of Pascal Soriot considering leaving
- Three analysts and one shareholder confirm the report
- Times article may also have impacted share price
Corona vaccination: booster with matched omicron vaccine possible.: Corona vaccination with an adapted vaccine for current Omikron variants is recommended for ...
stern.de/gesundheit/corona-impfung--auffrischung-mit-angepassten-omikron-impfungen-moeglich-33835190.html
Does It Matter Which COVID-19 Booster Shot You Get?: With a new booster available, it’s time to look at whether switching up your shots makes a difference in ...
time.com/6317294/which-covid-19-booster-shot-to-get/
Over 7 Million Americans Have So Far Received Updated Covid Vaccines, Here're Few Facts About Immunity Plans
indiatimes.com/trending/human-interest/updated-covid-vaccines-for-over-7-million-americans-617570.html
Quick Glance: Over 7 Million People Receive Updated COVID Vaccine
- FDA approved Pfizer and Moderna shots on Sept. 11, and distribution began on Sept. 12.
- 14 million vaccines have been shipped to pharmacies and other locations.
- The HHS numbers are likely an undercount due to the commercialization of the vaccine and lack of specific breakdowns.
- The latest vaccine effort is on par with the 2022 rollout of the bivalent booster shot.
How one company profited while delaying Narcan’s drugstore debut: Access to Narcan, a lifesaving drug that reverses overdoses, has been limited by Emergent ...
washingtonpost.com/business/2023/09/18/narcan-over-the-counter-delays-emergent-biosolutions/
Novavax's updated COVID shot shows immune response against subvariant Eris: Novavax Inc (NVAX.O) said on Tuesday its updated protein-based COVID-19 vaccine ...
reuters.com/business/healthcare-pharmaceuticals/novavaxs-updated-covid-vaccine-shows-response-against-eris-variant-2023-08-22/
Quick Glance: Novavax's updated COVID vaccine shows immune response to subvariant Eris
- Novavax's updated protein-based COVID-19 vaccine demonstrates immune response to emerging forms of coronavirus like the 'Eris' subvariant in animal studies.
- COVID infections and hospitalizations are increasing in the United States, Europe, and Asia, with recent cases attributed to the EG.5 subvariant - nicknamed 'Eris' - a descendant of the Omicron lineage that first emerged in November 2021.
- For the fall season, COVID vaccine makers are preparing with updated shots targeting the Omicron subvariant XBB.1.5.
- Both Moderna and Pfizer have stated that their vaccines also show promise against Eris.
oronavirus: manufacturers to begin shipping adjusted covid vaccines in September: Corona vaccines adapted to the XBB.1.5 variant are to come onto the market for ...
zeit.de/wissen/2023-08/coronavirus-impfstoffe-xbb-1-5-infektionen-anstieg
Quick Glance: Adapted BioNTech Vaccines for Covid-19 Variants Ready for Delivery
- New vaccines from BioNTech are set to launch in September, adapted to the prevailing Covid-19 variants.
- Vaccines for the new Covid-19 variants are nearing delivery.
- BioNTech and Pfizer have adapted their vaccine to the XBB.1.5 Omicron variant.
- Doctors can now administer them more easily.
Novavax’s updated protein-based COVID vaccine finally authorized by FDA: The shot already has CDC signoff and is available to everyone 12 and up.
arstechnica.com/health/2023/10/novavaxs-updated-protein-based-covid-vaccine-finally-authorized-by-fda/
Overdose reversal drug Narcan will be available to buy over-the-counter starting in September
abcnews.go.com/Health/overdose-reversal-drug-narcan-buy-counter-starting-september/story
Quick Glance: Narcan nasal spray available without prescription at pharmacies
- Three pharmacy chains to sell Narcan nationwide without prescription from September
- Walgreens to sell Narcan nasal spray for $44.99
- CVS Pharmacy and Rite Aid also selling Narcan over-the-counter for $44.99
- FDA approves Narcan for over-the-counter sale to combat opioid overdoses
Novavax touts non-mRNA COVID vaccine, future of domestic production remains uncertain
torontosun.com/news/national/novavax-touts-non-mrna-covid-vaccine-future-of-domestic-production-remains-uncertain
WHO recommends Oxford-Serum Institute malaria vaccine for global rollout: India malaria vaccine: India roll-out timelines not known immediately
business-standard.com/companies/news/oxford-serum-institute-of-india-malaria-vaccine-gets-who-approval-123100201024_1.html
J&J's Janssen to close part of its vaccine division -Telegraaf: Johnson & Johnson's (JNJ.N) Janssen division, which helped to develop its single-dose COVID-19 ...
reuters.com/business/healthcare-pharmaceuticals/jjs-janssen-close-part-its-vaccine-division-2023-08-23/
Quick Glance: J&J to Close Part of Vaccine Division -Telegraaf
- Janssen, a division of Johnson & Johnson, will close much of its vaccine research and development operations in the Netherlands.
- Johnson & Johnson confirmed plans to exit some of its vaccine research and development programs.
- The company continually assesses its global footprint, including the facility in Leiden, Netherlands.
- According to De Telegraaf, 2,500 people worked at Janssen in the Netherlands, with a quarter in the infectious diseases and vaccines section.
What to know about over-the-counter Narcan: Walgreens, Rite Aid and CVS will carry the spray, along with Walmart.
bostonherald.com/2023/09/08/what-to-know-about-over-the-counter-narcan/
AstraZeneca sues US over Medicare drug price negotiation plans: AstraZeneca (AZN.L) said on Friday it has sued the U.S. government to block parts of a program ...
reuters.com/legal/astrazeneca-files-litigation-challenge-inflation-reduction-act-2023-08-25/
Quick Glance: AstraZeneca sues Inflation Reduction Act
- AstraZeneca has filed a lawsuit against the Inflation Reduction Act.
- The Inflation Reduction Act includes a program for drug price negotiation.
- AstraZeneca aims to protect access to medicines for orphan indications.
Pfizer's updated COVID shot effective against 'Eris' variant in mice study: Pfizer Inc (PFE.N) said on Thursday its updated COVID-19 shot, which is being tested ...
reuters.com/business/healthcare-pharmaceuticals/pfizers-updated-covid-shot-effective-against-eris-variant-mice-study-2023-08-17/
Quick Glance: Pfizer's Updated COVID Shot Effective Against 'Eris' Variant in Mice Study
- Pfizer reports neutralizing activity of its updated COVID-19 shot against the 'Eris' subvariant in a study conducted on mice.
- Pfizer, along with its German partner BioNTech SE, and other COVID-19 vaccine makers like Moderna and Novavax, has developed versions of their shots targeting the XBB.1.5 subvariant.
- The EG.5 subvariant, nicknamed 'Eris', is similar to the XBB.1.5 subvariant and is a sub-lineage of the still-dominant Omicron variant.
- According to the latest government data, EG.5 accounted for over 17% of COVID-19 cases in the United States.
BofA reveals the global stocks that tend to outperform when the U.S. dollar rises
cnbc.com/2023/09/29/bofa-reveals-the-global-stocks-that-tend-to-outperform-when-the-us-dollar-rises.html
Paid articlePaid Hardware stores are filled with products that have met some type of standard (for example, for safety or efficiency). NIST’s work provides confidence in the ... Show more
Biomedical company Emergent BioSolutions announced Wednesday its opioid overdose-reversing naloxone product is expected to hit the shelves starting in ... Show more
COVID-19 hospitalizations in the US are on the rise again, but not like before: COVID-19 hospital admissions are inching upward in the United States since early ...
apnews.com/article/covid-cases-hospitalizations-increasing-9a831de37210c53c1ee48a30ad2ee611
COVID-19 hospitalizations in the US are on the rise again, but not like before: COVID-19 hospital admissions have been inching upward in the U.S ...
seattletimes.com/seattle-news/health/covid-19-hospitalizations-in-the-us-are-on-the-rise-again-but-not-like-before/
BioNTech: Corona vaccination season starts - more news expected today: The corona vaccination season begins with the BioNTech vaccine adapted to virus variants ...
deraktionaer.de/artikel/aktien/biontech-corona-impfsaison-startet-heute-weitere-news-erwartet-20339547.html
Moderna says new Covid vaccine was effective against Eris variant in early trial
cnbc.com/2023/08/17/moderna-covid-vaccine-effective-against-eris-fornax-variants.html
Quick Glance: Moderna's Updated COVID Vaccine Effective Against 'Eris' Variant in Humans
- Moderna announces initial study data showing effectiveness of updated COVID-19 vaccine against 'Eris' and 'Fornax' subvariants in humans.
- The updated vaccine is expected to be available in the coming weeks for the fall vaccination season, pending approval from health regulators in the US, Europe, and elsewhere.
- Moderna, along with Novavax, Pfizer, and BioNTech, has developed versions of their vaccines targeting the XBB.1.5 subvariant.
- Pfizer reports neutralizing activity against the Eris subvariant in a mouse study for its updated COVID-19 vaccine co-developed with BioNTech.
Emergent BioSolutions to lay off about 400 employees: Emergent BioSolutions (EBS.N) on Tuesday decided to cut 400 jobs and scale back operations at some its ...
reuters.com/business/healthcare-pharmaceuticals/emergent-biosolutions-lay-off-about-400-employees-2023-08-08/
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics